Back to top

rsi: Archive

Zacks Equity Research

TransDigm (TDG) Loses -5.84% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

TransDigm (TDG) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

TDGNegative Net Change

Zacks Equity Research

Down -5.5% in 4 Weeks, Here's Why Brinker International (EAT) Looks Ripe for a Turnaround

Brinker International (EAT) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

EATPositive Net Change

Zacks Equity Research

RxSight (RXST) Loses -16.11% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for RxSight (RXST) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

RXSTNegative Net Change

Zacks Equity Research

After Plunging -46.98% in 4 Weeks, Here's Why the Trend Might Reverse for Accolade (ACCD)

Accolade (ACCD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

ACCDNegative Net Change

Zacks Equity Research

NGL Energy Partners (NGL) Loses -5.86% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

NGL Energy Partners (NGL) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

NGLNegative Net Change

Zacks Equity Research

After Plunging -47.01% in 4 Weeks, Here's Why the Trend Might Reverse for Accolade (ACCD)

Accolade (ACCD) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

ACCDNegative Net Change

Zacks Equity Research

Down -88.84% in 4 Weeks, Here's Why HilleVax (HLVX) Looks Ripe for a Turnaround

HilleVax (HLVX) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

HLVXPositive Net Change

Zacks Equity Research

Here's Why Greenbrier (GBX) is Poised for a Turnaround After Losing -14.76% in 4 Weeks

The heavy selling pressure might have exhausted for Greenbrier (GBX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

GBXPositive Net Change

Zacks Equity Research

Down -23.29% in 4 Weeks, Here's Why You Should You Buy the Dip in Clean Energy Fuels (CLNE)

The heavy selling pressure might have exhausted for Clean Energy Fuels (CLNE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

CLNENegative Net Change

Zacks Equity Research

Down -19.96% in 4 Weeks, Here's Why You Should You Buy the Dip in Calavo (CVGW)

The heavy selling pressure might have exhausted for Calavo (CVGW) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

CVGWPositive Net Change

Zacks Equity Research

After Plunging -11.25% in 4 Weeks, Here's Why the Trend Might Reverse for EQT (EQT)

EQT (EQT) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

EQTNegative Net Change

Zacks Equity Research

Down -6.43% in 4 Weeks, Here's Why You Should You Buy the Dip in International Seaways (INSW)

International Seaways (INSW) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

INSWNegative Net Change

Zacks Equity Research

Down -7.69% in 4 Weeks, Here's Why You Should You Buy the Dip in Teekay Tankers (TNK)

Teekay Tankers (TNK) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

TNKNegative Net Change

Zacks Equity Research

Down -22.78% in 4 Weeks, Here's Why You Should You Buy the Dip in Cellectis (CLLS)

Cellectis (CLLS) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

CLLSNegative Net Change

Zacks Equity Research

Here's Why Melco (MLCO) is Poised for a Turnaround After Losing -18.13% in 4 Weeks

The heavy selling pressure might have exhausted for Melco (MLCO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

MLCONegative Net Change

Zacks Equity Research

Down -29.74% in 4 Weeks, Here's Why You Should You Buy the Dip in uniQure (QURE)

uniQure (QURE) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

QURENegative Net Change

Zacks Equity Research

CryoPort (CYRX) Loses -43.56% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for CryoPort (CYRX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

CYRXNegative Net Change

Zacks Equity Research

Down -5.13% in 4 Weeks, Here's Why You Should You Buy the Dip in TriMas (TRS)

The heavy selling pressure might have exhausted for TriMas (TRS) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

TRSPositive Net Change

Zacks Equity Research

After Plunging -13.21% in 4 Weeks, Here's Why the Trend Might Reverse for PDD Holdings Inc. Sponsored ADR (PDD)

The heavy selling pressure might have exhausted for PDD Holdings Inc. Sponsored ADR (PDD) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

PDDNegative Net Change

Zacks Equity Research

Prima BioMed (IMMP) Loses -34.84% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Prima BioMed (IMMP) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

IMMPNegative Net Change

Zacks Equity Research

Down -6.98% in 4 Weeks, Here's Why You Should You Buy the Dip in Louisiana-Pacific (LPX)

The heavy selling pressure might have exhausted for Louisiana-Pacific (LPX) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

LPXNegative Net Change

Zacks Equity Research

Down -17.15% in 4 Weeks, Here's Why Aptiv (APTV) Looks Ripe for a Turnaround

Aptiv (APTV) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.

APTVNegative Net Change

Zacks Equity Research

Haemonetics (HAE) Loses -5.16% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Haemonetics (HAE) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

HAENegative Net Change

Zacks Equity Research

New Found Gold Corp. (NFGC) Loses -23.16% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

New Found Gold Corp. (NFGC) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the near term.

NFGCNegative Net Change

Zacks Equity Research

After Plunging -18.51% in 4 Weeks, Here's Why the Trend Might Reverse for Gitlab (GTLB)

The heavy selling pressure might have exhausted for Gitlab (GTLB) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.

GTLBPositive Net Change